Skip to content

Clinical trials

Dwarfism, Pituitary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Clear all

252 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20016
20027
200315
200413
200515
20069
200715
200812
20099
201011
201110
20124
20139
201414
201514
20165
201711
20184
201911
20203
20216
20224
202313
20246
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed162
Terminated28
Unknown status27
Recruiting17
Withdrawn5
Not yet recruiting5
Active, not recruiting5
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S27
Pfizer17
Changchun GeneScience Pharmaceutical Co., Ltd.13
Merck KGaA, Darmstadt, Germany9
Columbia University8
Federico II University8
Versartis Inc.7
Ascendis Pharma Endocrinology Division A/S6
Lumos Pharma6
Ferring Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary252
Dwarfism14
Turner Syndrome12
Pituitary Diseases10
Endocrine System Diseases9
Hypopituitarism9
Failure to Thrive7
Insulin Resistance7
Acromegaly6
Kidney Failure, Chronic5

Trials

Showing 76 to 100 of 252. Each trial links to its page on Pharma Observatory.

152 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.